Skip to Main Content
Practices

Cosmetics

Print Version

With more than 11 billion personal care products sold each year in the U.S., the FDA holds cosmetic companies to a strict code of regulations to assure both product safety and that the public is not misled about the safety and efficacy of the products they buy.

Why Baker Donelson?


Attorneys dedicated to navigating complex FDA regulatory matters including responses to FDA inspections and Warning Letters, strategic product positioning and client organizational assessments
Represent national and international branded OTC and prescription drugs, medical devices, cosmetics, dietary supplements and medical foods
Active participation with private equity investors in the FDA-regulated space

Practice Overview


With more than 11 billion personal care products sold each year in the U.S., the FDA holds cosmetic companies to a strict code of regulations to assure both product safety and that the public is not misled about the safety and efficacy of the products they buy. Baker Donelson lawyers are well-versed in the requirements and we have helped guide our cosmetic company clients through the wide range of regulatory and legislative issues that can impact their industry and their products.

We have assisted cosmetics company clients, many of which source their ingredients outside the United States, in managing their quality assurance and traceability programs by conducting training sessions and conducting third party audits of their suppliers. We frequently develop labeling and packaging protocols to ensure cosmetic products are compliant with both FDA and CPSC requirements.

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept